CHU de Liege

Liège, Luik 4000

0 studies enrolling now · 1 studies all time

What they study most

Select Advanced Solid Tumors

Studies at this site

• Safety and Efficacy of IMC-F106C as a Single Agent and in Combination With Checkpoint Inhibitors — Running, not enrolling